Lynn J. Okamoto

Lynn J. Okamoto, Pharm.D. is the General Manager of the Health Care Analytics Group at United BioSource Corporation (UBC) in Bethesda, MD. Dr. Okamoto leads the health economic and policy efforts in the US, as well as interfacing with UBC's European operations on global issues. Dr. Okamoto has extensive experience in global management, as well as advanced leadership skills and command of strategic planning and implementation.

Dr. Okamoto has well over a decade of experience conducting health outcomes and pharmacoeconomic research and has held senior-level positions at NDCHealth and Glaxo Wellcome. Her expertise spans a range of therapeutic areas, including respiratory diseases, cardiology, infectious disease, and digestive disorders. She assisted in developing domestic and international pharmacoeconomic research strategy for respiratory (i.e., Flovent & Flonase) and cardiovascular (i.e., Flolan) products.

During her tenure at Glaxo Wellcome, Dr. Okamoto took an active role in pharmacoeconomic research at many levels, including decision modeling, strategic health outcomes research in support of new products, and regulatory strategy. Bringing this expertise to NDCHealth, she created and directed the company's Outcomes Research department. She went on to strengthen the Research and Consulting division by acquiring and integrating new data sources, and by creating and implementing sales strategies to capitalize on integrated patient-level data.

In her most recent position at NDCHealth, Dr. Okamoto served as Vice President and General Manager of the Intelligent Health Repository, the company's newest business unit that developed the integrated medical/pharmacy patient-linked claims repository, which led to the development of new products and services for customers across all healthcare markets.

Dr. Okamoto received her Doctor of Pharmacy from the University of Michigan, and her work in pharmacoeconomics has led to publications in healthcare journals, including Clinical Therapeutics, the Journal of Asthma, Pharmacotherapy, the American Journal of Managed Care, and the Annals of Allergy, Asthma & Immunology. Her research covers a wide variety of therapeutic areas and perspectives, from cost-of-illness analyses in respiratory care and influenza management, to quality-of-life studies in asthma. Dr. Okamoto's research has been exhibited internationally at conferences such as the International Society of Pharmacoeconomic and Outcomes Research Annual & European Conferences, and the European Respiratory Society Annual Congress.


Lynn J. Okamoto Lynn J. Okamoto, Pharm.D. is the General Manager of the Health Care Analytics Group at United BioSource Corporation (UBC) in Bethesda, MD. Dr. Okamoto leads the health economic and policy efforts in the US, as well as interfacing with UBC's European operations on global issues. Dr. Okamoto has extensive experience in global management, as well as advanced leadership skills and command of strategic planning and implementation. Dr. Okamoto has well over a decade of experience conducting health outcomes and pharmacoeconomic research and has held senior-level positions at NDCHealth and Glaxo Wellcome. Her expertise spans a range of therapeutic areas, including respiratory diseases, cardiology, infectious disease, and digestive disorders. She assisted in developing domestic and international pharmacoeconomic research strategy for respiratory (i.e., Flovent & Flonase) and cardiovascular (i.e., Flolan) products. During her tenure at Glaxo Wellcome, Dr. Okamoto took an active role in pharmacoeconomic research at many levels, including decision modeling, strategic health outcomes research in support of new products, and regulatory strategy. Bringing this expertise to NDCHealth, she created and directed the company's Outcomes Research department. She went on to strengthen the Research and Consulting division by acquiring and integrating new data sources, and by creating and implementing sales strategies to capitalize on integrated patient-level data. In her most recent position at NDCHealth, Dr. Okamoto served as Vice President and General Manager of the Intelligent Health Repository, the company's newest business unit that developed the integrated medical/pharmacy patient-linked claims repository, which led to the development of new products and services for customers across all healthcare markets. Dr. Okamoto received her Doctor of Pharmacy from the University of Michigan, and her work in pharmacoeconomics has led to publications in healthcare journals, including Clinical Therapeutics, the Journal of Asthma, Pharmacotherapy, the American Journal of Managed Care, and the Annals of Allergy, Asthma & Immunology. Her research covers a wide variety of therapeutic areas and perspectives, from cost-of-illness analyses in respiratory care and influenza management, to quality-of-life studies in asthma. Dr. Okamoto's research has been exhibited internationally at conferences such as the International Society of Pharmacoeconomic and Outcomes Research Annual & European Conferences, and the European Respiratory Society Annual Congress.